Creating new materials using engineered bacteria
From synthetic bacterial adhesions to synthetic bacterial materials
This study is exploring how to create special bacteria that can help make new medical tools and treatments, which could lead to better drugs and diagnostic devices for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-10911870 on NIH RePORTER |
What this research studies
This research focuses on engineering synthetic bacterial systems to create materials that can be used in various health applications, such as drug production and diagnostic devices. By developing new tools for controlling how bacteria stick together, the researchers aim to build complex multicellular structures that can perform specific functions. The project involves advanced techniques to manipulate bacterial adhesion at the molecular level, allowing for precise control over how these bacterial systems are assembled and how they behave. Patients may benefit from innovations in medical devices and treatments that arise from these engineered bacterial materials.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals interested in cutting-edge medical technologies and therapies related to bacterial applications.
Not a fit: Patients with conditions unrelated to bacterial infections or those not seeking innovative therapeutic approaches may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to groundbreaking advancements in medical devices and therapies that utilize engineered bacterial systems.
How similar studies have performed: While the approach of engineering bacterial systems is relatively novel, there have been successful applications of synthetic biology in other contexts, suggesting potential for success in this area as well.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Riedel-Kruse, Hans Ingmar — University of Arizona
- Study coordinator: Riedel-Kruse, Hans Ingmar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.